Head to head for first-timers
CoreAge Rx vs TeleCare Spot
CoreAge Rx and TeleCare Spot both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #1 for first-timers · Grade A
Mama-Match
Best for: Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Visit CoreAge RxTeleCare Spot
Rank #280 for first-timers · Grade C
Mama-Match
Best for: Someone who wants a phentermine option alongside the GLP-1 lane and will confirm whether the $79 consultation fee is actually credited before paying it.
Visit TeleCare SpotThe verdict for a first step
CoreAge Rx edges out TeleCare Spot on the Mama-Match Score, 94 to 41 (A vs C). Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
TeleCare Spot is still a genuine option — publishes per-program floors — from $299 semaglutide, from $399 tirzepatide — then adds a $79 consultation fee that its own page says only "may be applied" toward treatment. That conditional is why the consult is not counted as included. Both GLP-1 figures carry "From" and no ceiling is published. It also offers a cheaper phentermine program from $189/month, a real option for someone not seeking a GLP-1. The intake is a standard IntakeQ form on a separate host and responded normally when checked. What is missing is basic: the site never names the company behind it, and publishes no state list. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | TeleCare Spot |
|---|---|---|
| Mama-Match Score | 94/100 · A | 41/100 · C |
| Overall rank | #1 | #280 |
| Semaglutide | $99/mo | $299/mo |
| Tirzepatide | $149/mo | $399/mo |
| Coverage | All 50 states | Not stated on the site |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Mama-Match
CoreAge Rx
Rank #1 · Grade A
What we like
- One flat monthly price, with no teaser rate that jumps after the first month — you know the number before you commit
- A clinician reads your history and will genuinely talk timing with you if you're postpartum, breastfeeding, or trying to conceive
- Semaglutide and tirzepatide in one account, so you and a clinician can choose — and switch — without starting over
The caveats
- Not the rock-bottom teaser price — a couple of marketplaces dangle a lower first-month number
- Compounded medication only, not FDA-approved brand-name Ozempic or Wegovy
- A general metabolic program, not a dedicated OB-GYN or hormone consult
Mama-Match
TeleCare Spot
Rank #280 · Grade C
What we like
- Publishes distinct per-program rates rather than one vague range
- Offers a lower-cost phentermine program from $189/month alongside the GLP-1 options
- Intake is a standard IntakeQ form and responded normally when checked
The caveats
- A separate $79 one-time consultation fee, described only as one that may be applied toward treatment
- Both GLP-1 prices are prefixed "From" with no published ceiling
- No operating entity named anywhere on the public site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and TeleCare Spot with the other providers we review for women.
Or browse the full comparison hub.